Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Lipoprotein(a) [Lp(a)] concentration and apolipoprotein(a) [apo(a)] isoforms (identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] and Western blotting) were determined in a group of 508 asymptomatic Caucasian members of the community and in 318 Caucasian patients with angiographically defined coronary artery disease (CAD). Conventional risk factors for CAD were also measured. Lp(a) concentration was almost twice as high in subjects with CAD (geometric mean, 152 mg/L [geometric SD, 10 to 1398 mg/L]) as in asymptomatic control subjects (geometric mean, 84 mg/L [geometric SD, 21 to 334 mg/L]). Asymptomatic women had higher concentrations of Lp(a) than asymptomatic men. Patients with CAD were older and were more likely to have smoked and to have a first-degree relative with premature CAD (< 55 years of age), and a higher proportion were male. Patients with CAD had higher concentrations of Lp(a) independently of the number of isoform bands expressed. When apo(a) isoforms were allocated to 1 of 10 classes on the basis of their molecular size (Rf versus apoB in SDS-PAGE), patients with CAD did not express an excess of low-molecular-mass (higher concentration) isoforms but did express a higher proportion of double-band phenotypes with fewer "null" phenotypes. The relationship between the two isoform bands in a double-band phenotype was the same in both populations. Isoform mobility was defined as a continuous variable equal to the mobility of a single isoform band (single-band phenotypes) or the mean of the two isoforms in a double-band phenotype. Two variables, isoform mobility and the number of isoform bands expressed, were used to summarize the large range of isoform patterns (at least 45) that could be identified. Isoform mobility, the number of isoform bands expressed, and the presence of CAD were the three most important independent predictors of Lp(a) concentration (descending order). Only sex and LDL cholesterol were additional independent predictors of Lp(a) concentration in step-wise regression models including a wide range of demographic factors and lipid and glycemic risk factors. We conclude that Lp(a) concentration is associated with CAD independently of the isoform pattern expressed. The apo(a) gene locus exerts a strong control over circulating Lp(a) concentration, and a better understanding of the control of expression of the apo(a) gene will be essential to understand the relationship between Lp(a) and CAD.

[1]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[2]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[3]  R. Ferrell,et al.  Expressed hypervariable polymorphism of apolipoprotein (a). , 1991, American journal of human genetics.

[4]  R. Krauss,et al.  Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. , 1992, American Journal of Human Genetics.

[5]  S. Marcovina,et al.  Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. , 1993, Biochemical and biophysical research communications.

[6]  J. Fruchart,et al.  Black-white differences in serum Lp(a) lipoprotein levels. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[7]  J. Guyton,et al.  Isolation and characterization of the two major apoproteins in human lipoprotein [a]. , 1987, Journal of lipid research.

[8]  G. Fless Chapter 3 – Heterogeneity of Particles Containing the Apo B-Apo(a) Complex , 1990 .

[9]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[10]  K. Alberti,et al.  Microalbuminuria and associated cardiovascular risk factors in the community. , 1992, Atherosclerosis.

[11]  M. Debakey,et al.  Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. , 1989, Arteriosclerosis.

[12]  J. Morrisett,et al.  Chapter 4 – Structural Properties of Apo(a): A Major Apoprotein of Human Lipoprotein(a) , 1990 .

[13]  D. Slone,et al.  Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic , 1965, Diabetes.

[14]  V. Armstrong,et al.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.

[15]  A. Scanu,et al.  A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.

[16]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.

[17]  K. Sperling,et al.  Large human Y chromosome with two fluorescent bands , 1971, Clinical genetics.

[18]  D. Rouy,et al.  Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  V. Armstrong,et al.  Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation. , 1991, Journal of lipid research.

[20]  A. Scanu,et al.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.

[21]  E. Boerwinkle,et al.  The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  M. Leon,et al.  Emergent Use of Balloon‐Expandable Coronary Artery Stenting for Failed Percutaneous Transluminal Coronary Angioplasty , 1992, Circulation.

[23]  G. Utermann,et al.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.

[24]  A. Sharrett,et al.  Lipoprotein[a] as a risk factor for preclinical atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  S. Srinivasan,et al.  Racial (Black‐White) Differences in Serum Lipoprotein (a) Distribution and Its Relation to Parental Myocardial Infarction in Children: Bogalusa Heart Study , 1991, Circulation.

[26]  K. Berg A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[27]  S J Pocock,et al.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. , 1981, British medical journal.

[28]  G. De Backer,et al.  Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. , 1992, Clinical chemistry.

[29]  K. Berg,et al.  Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor , 1981, Clinical genetics.

[30]  D. Rader,et al.  Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. , 1993, The Journal of clinical investigation.

[31]  G. Dahlén Chapter 11 – Incidence of Lp(a) Lipoprotein among Populations , 1990 .

[32]  P. Savage,et al.  Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  E. Boerwinkle,et al.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. , 1991, The Journal of clinical investigation.

[34]  W. Kohr,et al.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Boerwinkle,et al.  Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Farrer,et al.  A simple, sensitive technique for classification of apolipoprotein(a) isoforms by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[37]  G. Kostner,et al.  Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors. , 1990, Journal of lipid research.

[38]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[39]  G. Assmann,et al.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. , 1990, Clinical chemistry.

[40]  H. Keen Diabetes Survey in Bedford 1962 , 1964, Proceedings of the Royal Society of Medicine.

[41]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[42]  A. Scanu,et al.  Isolation of apolipoprotein(a) from lipoprotein(a). , 1985, Journal of lipid research.

[43]  J. Breslow,et al.  Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. , 1989, The Journal of clinical investigation.

[44]  R. Lawn,et al.  5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[46]  C. Ehnholm,et al.  Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. , 1971, Biochimica et biophysica acta.

[47]  J. Beranek Are restenosis cells containing nonmuscle myosin really vascular smooth muscle cells? , 1992, Circulation.

[48]  A. Soutar,et al.  Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration. , 1991, Atherosclerosis.

[49]  S. Marcovina,et al.  The unique lipoprotein(a): properties and immunochemical measurement. , 1990, Clinical chemistry.

[50]  E. Plow,et al.  Chapter 8 – Relationship between Plasminogen Receptors and Lp(a) , 1990 .

[51]  E. Boerwinkle,et al.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.

[52]  H. Yamaguchi,et al.  Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases. , 1992, Atherosclerosis.

[53]  L. Hunt,et al.  APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE , 1988, The Lancet.

[54]  M. Frick,et al.  Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease , 1974, Clinical genetics.

[55]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[56]  B. Lewis,et al.  Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain , 1988, British medical journal.

[57]  W. Patsch,et al.  Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. , 1990, Journal of lipid research.

[58]  M. Kameyama,et al.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.